Showing 821-830 of 1317 results for "".
Currents: Picture This: Clinical Updates for Dermatologists
https://practicaldermatology.com/topics/atopic-dermatitis/currents-picture-this-clinical-updates-for-dermatologists/23609/New in My Practice: At-Home Device/New Products
https://practicaldermatology.com/columns/new-products/new-in-my-practice-at-home-devicenew-products/23603/Protect Your Practice from Fraud, Part 1
https://practicaldermatology.com/topics/practice-management/protect-your-practice-from-fraud-part-1/23588/Part 1 of this 2-part series offers a review of areas of your practice that may be susceptible to fraud and what precautions to take to reduce your risk.PBM Restrictions Force Dermatologists to Consider OTC Products
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/pbm-restrictions-force-dermatologists-to-consider-otc-products/23578/The latest generation of OTC products for some common dermatologic diseases often feature innovative formulations and clinical studies to show efficacy.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-25/23543/Limited Liability Companies and Family Limited Partnerships, Part 2
https://practicaldermatology.com/topics/practice-management/limited-liability-companies-and-family-limited-partnerships-part-2/23529/How to maximize the protections of LLCs and FLPs.Credentialing: Building Confidence and Trust
https://practicaldermatology.com/topics/practice-management/credentialing-building-confidence-and-trust/23498/Tips for training staff to answer questions and use credentialing throughout the patient journey to earn loyalty.Catch The Wave Of The Future
https://practicaldermatology.com/topics/practice-management/catch-the-wave-of-the-future/23478/Clearwave’s patient engagement platform may help create zero-contact offices.Data Show Impact of Dupilumab on Patients with Coexistent Atopic Diseases
https://practicaldermatology.com/topics/practice-management/data-show-impact-of-dupilumab-on-patients-with-coexistent-atopic-diseases/23477/Cutaneous T-Cell Lymphoma: Mogamulizumab as a Novel Treatment for Refractory Mycosis Fungoides and Sezary Syndrome
https://practicaldermatology.com/youngmd-connect/resident-resource-center/Cutaneous-T-Cell-Lymphoma-Mogamulizumab-as-a-Novel-Treatment-for-Refractory-Mycosis-Fungoides-and-Sezary-Syndrome/23409/An overview of the diagnosis and prognosis of CTCL.